The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The pulmonary arterial hypertension market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 8%, as per The Business Research Company’s market report!

Read More On The Pulmonary Arterial Hypertension Market Report 2022 – https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report

The Pulmonary Arterial Hypertension Market Size In 2022 And Forecast

The global pulmonary arterial hypertension market is expected to grow from $6.59 billion in 2021 to $7.04 billion in 2022 at a compound annual growth rate (CAGR) of 6.85%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The pulmonary arterial hypertension market is expected to reach $9.65 billion in 2026 at a CAGR of 8.22%.

The pulmonary arterial hypertension market consists of sales of drugs by entities (organizations, sole proprietors, and partnerships) that are used in the treatment of pulmonary arterial hypertension disease which is a rare progressive disorder characterized by high blood pressure in the arteries of the lungs.

Request for A Sample Of The Global Pulmonary Arterial Hypertension Market Report:

 https://www.thebusinessresearchcompany.com/sample.aspx?id=5954&type=smp

Increase In The Prevalence Of Pulmonary Arterial Hypertension Disease Is Driving The Growth Of The Pulmonary Arterial Hypertension Market

According to a study published by the National Organization for Rare Disorders, Inc., new cases of PAH are estimated to occur in one to two individuals per million each year in the USA, which equates to 500–1000 new cases each year, and Europe is expected to have similar incidence rates.

Competitive Landscape And The Regional Analysis Of The Pulmonary Arterial Hypertension Market

Major players in the pulmonary arterial hypertension market are United Therapeutics Corporation, Bayer AG, Gilead Sciences Inc., Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Sandoz AG, Lupin Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Acceleron Pharma Inc., Eli Lilly and Company, Actelion Pharmaceuticals US Inc, Natco Pharma Ltd, Zydus Pharmaceutical USA, and Liquidia Technologies Inc.

Additionally, as per TBRC’s research – North America was the largest region in the pulmonary arterial hypertension market in 2021 holding the largest market share.

The Pulmonary Arterial Hypertension Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pulmonary arterial hypertension market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the pulmonary arterial hypertension market.

Technological Advancement – A Key Trend In The Pulmonary Arterial Hypertension Market

The companies operating in the pulmonary arterial hypertension drug sector are focusing on developing new medicines to improve and cure the diseases.

Pulmonary Arterial Hypertension Market Segmentation By The Business Research Company

1) By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators

2) By Route of Administration: Oral, Intravenous/ subcutaneous, Inhalational

3) By Distribution channel: Retail, Online

Here Are Some Reports Related To The Pulmonary Arterial Hypertension Market –

Anti-Hypertensive Drugs Global Market Report 2022

Wearable Medical Devices Global Market Report 2022

Wearable ECG Monitors Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: